a-Cyclohexyl-a-phenyl-1-pyrrolidinepropanol hydrochloride
CAS: 1508-76-5
Ref. 3D-FP27169
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Información del producto
- a-Cyclohexyl-a-phenyl-1-pyrrolidinepropanol hydrochloride(±)-Procyclidine hydrochloride1-Cyclohexyl-1-phenyl-3-pyrrolidino-1-propa nol hydrochlorideProcyclidine hydrochloride
- 1-Cyclohexyl-1-Phenyl-3-(Pyrrolidin-1-Yl)Propan-1-Ol Hydrochloride (1:1)
- 1-Cyclohexyl-1-Phenyl-3-Pyrrolidino-1-Propanol Hydrochloride
- 1-Cyclohexyl-1-phenyl-3-(pyrrolidin-1-yl)propan-1-ol hydrochloride
- 1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride
- 1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, monohydrochloride
- 1-Pyrrolidinepropanol, α-cyclohexyl-α-phenyl-, hydrochloride
- 1-Pyrrolidinepropanol, α-cyclohexyl-α-phenyl-, hydrochloride (1:1)
- Arpicolin
- Kemadrin
- Ver más sinónimos
- Kemadrin hydrochloride
- Osnervan
- Procyclidine HCl
- Procyclidine hydrochloride [USAN]
- Tricyclamol hydrochloride
- Unii-Cqc932Z7Yw
- alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol hydrochloride
- (+-)-Procyclidine hydrochloride
- Procyclidine hydrochloride
a-Cyclohexyl-a-phenyl-1-pyrrolidinepropanol hydrochloride is a drug that belongs to the group of pharmacological agents. It has been shown to have an effect on locomotor activity in rats, as well as effects on serum levels of dopamine and gamma-aminobutyric acid (GABA). This compound also has an effect on prolactin levels and detrusor muscle contractions in rats. The clinical relevance of this drug is still unknown, but it may be used as a procyclidine substitute for treating Parkinson's disease.
Propiedades químicas
Consulta técnica sobre: 3D-FP27169 a-Cyclohexyl-a-phenyl-1-pyrrolidinepropanol hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.